Recently Visited

{{scheme.chgp}}%

Premium

{{ scheme.tag == 'Stock' || scheme.tag == 'News' ? 'View Reco' : 'View Ratings' }}

{{scheme.scoreText}} | Score {{scheme.score}}

Most Searched

{{scheme.chgp}}%

Premium

{{ scheme.tag == 'Stock' || scheme.tag == 'News' ? 'View Reco' : 'View Ratings' }}

{{scheme.scoreText}} | Score {{scheme.score}}

No Matches Found

Kiromic Biopharma, Inc.

Is Kiromic Biopharma, Inc. overvalued or undervalued?

As of October 5, 2023, Kiromic Biopharma, Inc. is considered overvalued due to its high price-to-earnings ratio of 45.2, a price-to-book ratio of 6.8, and a negative return on equity of -12%, all of which indicate poor financial health compared to its peers.

Jun 25 2025 09:14 AM IST

Share Via

{{stock_short.stock.price_difference.value}} ({{stock_short.stock.price_percentage.value}}%)

{{ra.stock_return.chgp}}%

{{ra.sensex_return.chgp}}%

Change%

Figures in Rs cr

Is Kiromic Biopharma, Inc. technically bullish or bearish?

As of October 1, 2023, there is insufficient technical data for Kiromic Biopharma, Inc. to determine if it is bullish or bearish.

Jun 25 2025 09:00 AM IST

Share Via

${{list.post_title_sep}}$

Share Via

Our weekly and monthly stock recommendations are here

Stock of the Week

Industry

Market Cap

Date of Entry

Entry Price

Target Price

{{sm.target_price }} ({{sm.performance_target }}%)

Holding Duration

Last 1 Year Return

{{sm.performance_1y}}%

Upgrade to Unlock the Latest Stock of the Week

Stock of the Month

{{sm.comp_name}} price as on {{sm.todays_date}}

₹{{sm.price_as_on}} ({{sm.performance}}%)

Industry

Market Cap

Date of Entry

Entry Price

Last 1 Year Return

{{sm.performance_1y}}%

Upgrade to Unlock the Latest Stock of the Month

Kiromic Biopharma, Inc.

Is Kiromic Biopharma, Inc. technically bullish or bearish?

{{list.post_title}}

{{list.post_title}}